Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer Therapy
Rachna T. Shroff, Pavani Chalasani, Ran Wei, Daniel Pennington, Grace Quirk, Marta V. Schoenle, Jennifer L. Uhrlaub, Tyler J. Ripperger, Mladen Jergović, Shelby Dalgai, Alexander Wolf, Hytham Hammad, Amy Carrier, Aaron J. Scott, Janko Nikolich-Žugich, Michael Worobey, Ryan Sprissler, Michael Dake, Bonnie J. LaFleur, View ORCID ProfileDeepta Bhattacharya
doi: https://doi.org/10.1101/2021.05.13.21257129
Rachna T. Shroff
1Division of Hematology and Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson, AZ, USA
Pavani Chalasani
1Division of Hematology and Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson, AZ, USA
Ran Wei
2Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ, USA
Daniel Pennington
1Division of Hematology and Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson, AZ, USA
Grace Quirk
3BIO5 Institute, University of Arizona, Tucson, AZ, USA
Marta V. Schoenle
2Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ, USA
3BIO5 Institute, University of Arizona, Tucson, AZ, USA
Jennifer L. Uhrlaub
2Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ, USA
Tyler J. Ripperger
2Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ, USA
Mladen Jergović
2Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ, USA
Shelby Dalgai
1Division of Hematology and Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson, AZ, USA
Alexander Wolf
1Division of Hematology and Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson, AZ, USA
Hytham Hammad
1Division of Hematology and Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson, AZ, USA
Amy Carrier
1Division of Hematology and Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson, AZ, USA
Aaron J. Scott
1Division of Hematology and Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson, AZ, USA
Janko Nikolich-Žugich
2Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ, USA
3BIO5 Institute, University of Arizona, Tucson, AZ, USA
6University of Arizona Center on Aging, University of Arizona College of Medicine, Tucson, AZ, USA
Michael Worobey
3BIO5 Institute, University of Arizona, Tucson, AZ, USA
4Department of Ecology and Evolutionary Biology, University of Arizona, Tucson, AZ 85721, USA
Ryan Sprissler
3BIO5 Institute, University of Arizona, Tucson, AZ, USA
5University of Arizona Genomics Core and the Arizona Research Labs, University of Arizona Genetics Core, University of Arizona, Tucson, AZ, USA
Michael Dake
7Office of the Senior Vice-President for Health Sciences, University of Arizona, Tucson, AZ, USA
Bonnie J. LaFleur
3BIO5 Institute, University of Arizona, Tucson, AZ, USA
Deepta Bhattacharya
2Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ, USA
3BIO5 Institute, University of Arizona, Tucson, AZ, USA
Data Availability
Raw data and statistical analysis code are available upon request to the corresponding authors. Figures 1-4 have associated raw data. Data will be made available without restrictions unless linked to identifiers in patient health information.
Posted May 14, 2021.
Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer Therapy
Rachna T. Shroff, Pavani Chalasani, Ran Wei, Daniel Pennington, Grace Quirk, Marta V. Schoenle, Jennifer L. Uhrlaub, Tyler J. Ripperger, Mladen Jergović, Shelby Dalgai, Alexander Wolf, Hytham Hammad, Amy Carrier, Aaron J. Scott, Janko Nikolich-Žugich, Michael Worobey, Ryan Sprissler, Michael Dake, Bonnie J. LaFleur, Deepta Bhattacharya
medRxiv 2021.05.13.21257129; doi: https://doi.org/10.1101/2021.05.13.21257129
Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer Therapy
Rachna T. Shroff, Pavani Chalasani, Ran Wei, Daniel Pennington, Grace Quirk, Marta V. Schoenle, Jennifer L. Uhrlaub, Tyler J. Ripperger, Mladen Jergović, Shelby Dalgai, Alexander Wolf, Hytham Hammad, Amy Carrier, Aaron J. Scott, Janko Nikolich-Žugich, Michael Worobey, Ryan Sprissler, Michael Dake, Bonnie J. LaFleur, Deepta Bhattacharya
medRxiv 2021.05.13.21257129; doi: https://doi.org/10.1101/2021.05.13.21257129
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2841)
- Dermatology (243)
- Emergency Medicine (428)
- Epidemiology (12551)
- Forensic Medicine (10)
- Gastroenterology (803)
- Genetic and Genomic Medicine (4425)
- Geriatric Medicine (401)
- Health Economics (715)
- Health Informatics (2849)
- Health Policy (1047)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4184)
- Nursing (222)
- Nutrition (617)
- Oncology (2200)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (267)
- Palliative Medicine (81)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6775)
- Radiology and Imaging (1487)
- Respiratory Medicine (899)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (174)